Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2003
10/15/2003CN1449441A Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone
10/15/2003CN1449250A Novel insecticidal toxins derived from bacillus thuringiensis insecticidal crystal proteins
10/15/2003CN1448403A Human protein with cancer cell growth suppressing function and its coding sequence
10/15/2003CN1448402A Polypeptide-human anemia related protein 35.4 and polynucleotide for coding said polypeptide
10/15/2003CN1124348C Multi-functional hematopoietic receptor agonists
10/15/2003CN1124342C Neurotrophin-3, neurotrophic factor related to nerve growth and brain derived neurotrophic factor
10/15/2003CN1124341C Monoclonal antibody of p-methyl benzedrine with specificity, hybridoma producing same and kit containing monoclonal antibody and its use
10/15/2003CN1124284C High-effective broad-spectrum antibody for inhibiting growth and metastasis of tumour
10/14/2003US6632935 Genome DNA of bacterial symbiont of aphids
10/14/2003US6632926 Amino acids inserted in hypervariable region; heavy chain variable domain of an antibody that binds vascular endothelial growth factor
10/14/2003US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/14/2003US6632790 Recombinant DNA produced; pathogen free; high purity
10/14/2003US6632638 As a fusion partner; useful for suppressing the competing aggregation pathway and facilitating proper folding; escherichia coli
10/14/2003US6632637 Vectors and methods for recombinant protein expression
10/14/2003US6632635 Methods of refolding proteins
10/14/2003US6632624 Use immunoassay for precise measurement of levels of intact chromogranin A and the levels of major fragments found in circulating blood
10/14/2003US6632618 Morphogenic protein-specific cell surface receptors and uses therefor
10/14/2003US6632601 Immunoassays for anti-HCV antibodies
10/14/2003US6632438 Vaccines
10/14/2003US6632426 G-CSF analog compositions and methods
10/14/2003US6632424 Stimulate proliferation of hematopoietic stem or progenitor cells
10/14/2003CA2167521C Compositions and methods for producing sialyltransferases
10/14/2003CA2080018C Novel t-cell lymphoma cdna clones
10/09/2003WO2003083660A1 Adaptive behavioral intrusion detection systems and methods
10/09/2003WO2003083435A2 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification
10/09/2003WO2003083113A2 Growth regulating proteins
10/09/2003WO2003083093A1 Host cells having improved cell survival properties and methods to generate such cells
10/09/2003WO2003083066A2 Methods for increasing polypeptide production
10/09/2003WO2003083056A2 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof
10/09/2003WO2003083043A2 Methods for producing secreted polypeptides having l-asparaginase activity
10/09/2003WO2003083041A2 Cripto-specific antibodies
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082923A1 Process for crosslinking polypeptides
10/09/2003WO2003082910A1 Chimeric delta endotoxin protein of cry1ea and cry1ca
10/09/2003WO2003082349A1 Treatment methods for eotaxin mediated inflammatory conditions
10/09/2003WO2003082206A2 Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses
10/09/2003WO2003046558A3 Complement c3 precursor biopolymer markers predictive of type ii diabetes
10/09/2003WO2003040170A3 Antibodies to cd40
10/09/2003WO2003035686A3 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
10/09/2003WO2003014149A3 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003000878A3 Use of fkbp chaperones as expression tool
10/09/2003WO2002097075A3 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002086096A3 Methods of producing or identifying intrabodies in eukaryotic cells
10/09/2003WO2002077016A3 Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefore
10/09/2003WO2002074250A3 Methods and reagents for decreasing clinical reaction to allergy
10/09/2003WO2002060955A3 Modified antibodies and methods of use
10/09/2003WO2002059154A3 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
10/09/2003WO2002053743A3 Mammalian tribbles signaling pathways and methods and reagents related thereto
10/09/2003WO2002040676A3 Mutant allergens
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002020563A3 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN
10/09/2003WO2002012290A3 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
10/09/2003WO2002010382A3 Trp8, trp9 and trp10, markers for cancer
10/09/2003US20030192077 Production of silk-like proteins in plants
10/09/2003US20030191299 PRO polypeptides fused to heterologous polypeptide sequences
10/09/2003US20030191290 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191289 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191288 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191287 Antibody that binds to the protein; given amino acid sequence
10/09/2003US20030191284 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191282 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030191281 Of given amino acid sequence; culturing host cells transformed with vector
10/09/2003US20030191280 Class ii cytokine receptor-7
10/09/2003US20030191062 Bone marrow specific protein
10/09/2003US20030191059 Antitumor agents; anticancer agents; wound healing agents; cardiovascular disorders
10/09/2003US20030191052 Infection therapy; binding of mannan lecithin to protein
10/09/2003US20030190752 Escherichia coli csrB gene, RNA encoded thereby, and methods of use thereof
10/09/2003US20030190751 Directed switch-mediated DNA recombination
10/09/2003US20030190749 Expression element that comprises a gene linked to sequences that are inducible and/or repressible; mutations; useful in diagnositics, therapeutics and drug discovery
10/09/2003US20030190740 Protease and peptidase-resistant proteins; Drug screening for control of cell division, apoptosis; for cancer treatment
10/09/2003US20030190739 Tankyrase2 materials and methods
10/09/2003US20030190737 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
10/09/2003US20030190731 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190730 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190729 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190728 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190727 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190726 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190725 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190724 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190723 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190722 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190721 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190720 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190719 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190718 Used as pharmaceuticals, diagnostics, biosensors and bioreactors; PRO polypeptides
10/09/2003US20030190717 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190716 Used to produce pharmaceuticals, diagnostics, biosensors, bioreactors; PRO polypeptides
10/09/2003US20030190708 Novel hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use
10/09/2003US20030190707 17 human secreted proteins
10/09/2003US20030190705 Method of humanizing immune system molecules
10/09/2003US20030190699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190698 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190683 Minicell-based rational drug design
10/09/2003US20030190674 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
10/09/2003US20030190669 Humanized antibody.
10/09/2003US20030190668 Identification and isolation of DNA and recombinant production of polypeptides
1 ... 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 ... 1125